Metronomic chemotherapy and nanocarrier platforms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metronomic chemotherapy and nanocarrier platforms

Published:2017-08 Issue: Volume:400 Page:232-242
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Abu Lila Amr S.,Ishida Tatsuhiro

Funder

Takahashi Industrial and Economic Research Foundation

Takeda Science Foundation

Uehara Memorial Foundation

Ministry of Education, Culture, Sports, Science and Technology, Japan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference114 articles.

1. Strategies for targeting tumors and tumor vasculature for cancer therapy;Sreeramoju;Adv. Genet.,2010

2. Targeting tumor vasculature: expanding the potential of DNA cancer vaccines;Ugel;Cancer Immunol. Immunother.,2015

3. Recent advances in tumor vasculature targeting using liposomal drug delivery systems;Abu Lila;Expert Opin. Drug Deliv.,2009

4. Tumor origin of endothelial cells in human neuroblastoma;Pezzolo;J. Clin. Oncol.,2007

5. The next frontier of molecular medicine: delivery of therapeutics;Jain;Nat. Med.,1998

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of drug dispersion on tumor-effector dynamics during combined chemo-immunotherapy with sensitivity analysis;Applied Mathematical Modelling;2024-10

2. Accumulation of liposomes in metastatic tumor sites is not necessary for anti-cancer drug efficacy;Journal of Translational Medicine;2024-07-03

3. Modulating cancer mechanopathology to restore vascular function and enhance immunotherapy;Cell Reports Medicine;2024-07

4. Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence;Cancer Letters;2024-07

5. CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease;Annals of Hematology;2023-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3